Paul Stacey
Director of Finance/CFO bij GABY INC.
Vermogen: 1 667 $ op 31-03-2024
Profiel
Paul Stacey is currently the Chief Financial Officer & Vice President at GABY, Inc. He previously worked as the Chief Financial Officer at Metagreen and The Hempshire Group, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GABY, INC.
0.05% | 20-06-2023 | 333 333 ( 0.05% ) | 1 667 $ | 31-03-2024 |
Actieve functies van Paul Stacey
| Bedrijven | Functie | Begin |
|---|---|---|
| GABY INC. | Director of Finance/CFO | 01-03-2022 |
Eerdere bekende functies van Paul Stacey
| Bedrijven | Functie | Einde |
|---|---|---|
| THE HEMPSHIRE GROUP, INC. | Director of Finance/CFO | 14-02-2024 |
Metagreen
 Metagreen Pharmaceuticals: OtherHealth Technology Metagreen provides health care and pharmaceutical technology services. It develops novopure technology for extraction and clarionworks technology for purification and formulations. The company was founded by Randall B. Murphy in 2015 and is headquartered in Los Angeles, CA. | Director of Finance/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GABY INC. | Consumer Non-Durables |
| THE HEMPSHIRE GROUP, INC. | Consumer Non-Durables |
| Bedrijven in privébezit | 1 |
|---|---|
Metagreen
Metagreen Pharmaceuticals: OtherHealth Technology Metagreen provides health care and pharmaceutical technology services. It develops novopure technology for extraction and clarionworks technology for purification and formulations. The company was founded by Randall B. Murphy in 2015 and is headquartered in Los Angeles, CA. | Health Technology |
